306 related articles for article (PubMed ID: 30826427)
1. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2: A simple molecule with complex functions.
Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
[TBL] [Abstract][Full Text] [Related]
3. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
4. PKM2, a potential target for regulating cancer.
Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
[TBL] [Abstract][Full Text] [Related]
5. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect.
Upadhyay S; Khan S; Hassan MI
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189089. PubMed ID: 38458358
[TBL] [Abstract][Full Text] [Related]
6. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
Konno M; Hamabe A; Doki Y; Mori M; Ishii H
Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
[TBL] [Abstract][Full Text] [Related]
7. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
8. The role of PKM2 in cancer progression and its structural and biological basis.
Wu B; Liang Z; Lan H; Teng X; Wang C
J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
[TBL] [Abstract][Full Text] [Related]
9. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
10. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
11. PKM2, cancer metabolism, and the road ahead.
Dayton TL; Jacks T; Vander Heiden MG
EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted regulation and functions of PKM2 in tumor progression.
Li Z; Yang P; Li Z
Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
[TBL] [Abstract][Full Text] [Related]
13. [Metabolism enzyme controls cancer stemness].
Konno M; Doki Y; Mori M; Ishii H
Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
[TBL] [Abstract][Full Text] [Related]
14. Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.
İlhan M
Neoplasma; 2022 Jul; 69(4):747-754. PubMed ID: 35471978
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
[TBL] [Abstract][Full Text] [Related]
16. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer.
Li L; Zhu L; Hao B; Gao W; Wang Q; Li K; Wang M; Huang M; Liu Z; Yang Q; Li X; Zhong Z; Huang W; Xiao G; Xu Y; Yao K; Liu Q
Oncotarget; 2017 May; 8(20):33047-33063. PubMed ID: 28380434
[TBL] [Abstract][Full Text] [Related]
17. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer.
Prakasam G; Iqbal MA; Bamezai RNK; Mazurek S
Front Oncol; 2018; 8():22. PubMed ID: 29468140
[TBL] [Abstract][Full Text] [Related]
19. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
van Niekerk G; Engelbrecht AM
Cell Oncol (Dordr); 2018 Aug; 41(4):343-351. PubMed ID: 29797241
[TBL] [Abstract][Full Text] [Related]
20. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]